Evaluation of Antibiotic Prescribing Practices in Infection Management: A Retrospective Observational Audit in a UK District General Hospital
DOI:
https://doi.org/10.54536/ijphn.v2i2.8212Keywords:
Antimicrobial Stewardship, Blood Culture, Drug Resistance, Prescriptions, United Kingdom HospitalsAbstract
Antimicrobial resistance (AMR) is a significant global health threat driven largely by inappropriate antibiotic use. Optimising prescribing practices through antimicrobial stewardship is essential to reduce resistance and improve patient outcomes. To evaluate antibiotic prescribing practices in infection management within a UK district general hospital general internal medicine ward, focusing on compliance with guidelines, antibiotic consumption, microbiological investigation, and treatment outcomes. A retrospective observational audit was conducted between March and May 2025 on a general internal medicine ward at Eastbourne District General Hospital. Data from 65 antibiotic prescriptions were analysed and compared against NICE guideline NG15, the UKHSA “Start Smart - Then Focus” framework, and local antimicrobial guidelines. Co-amoxiclav accounted for 77% (50/65) of prescriptions, followed by levofloxacin (15%), meropenem (15%), and vancomycin (2%). Respiratory infections and sepsis were the most common indications. Repeat antibiotic courses were required in 68–70% of patients. Blood cultures were not performed in up to 18% of cases. The audit highlights several important challenges in antibiotic prescribing, including a high reliance on empirical therapy, frequent repeat prescribing, and inconsistent microbiological testing. Strengthening antimicrobial stewardship interventions, particularly 48–72-hour antibiotic review, improved biological investigation, and enhanced documentation, is necessary to improve prescribing practices and reduce AMR risk.
References
(UKHSA), U. H. S. A. (2025). English surveillance programme for antimicrobial utilisation and resistance (ESPAUR). Report 2024 to 2025. U. H. S. A. (UKHSA). https://assets.publishing.service.gov.uk/media/6a0346098cc72d2f863ea828/ESPAUR-report-2024-to-2025-private-prescribing-update.pdf
Agency, U. H. S. (2023). Start smart then focus: antimicrobial stewardship toolkit for inpatient care settings.
Aiesh, B. M., Nazzal, M. A., Abdelhaq, A. I., Abutaha, S. A., Zyoud, S. e. H., & Sabateen, A. (2023). Impact of an antibiotic stewardship program on antibiotic utilization, bacterial susceptibilities, and cost of antibiotics. Scientific Reports, 13(1), 5040.
Authority, H. R. (2017). Is my study research? Government of United Kingdom. https://www.hra-decisiontools.org.uk/research/docs/definingresearchtable_oct2017-1.pdf
Barlam, T. F., Cosgrove, S. E., Abbo, L. M., MacDougall, C., Schuetz, A. N., Septimus, E. J., Srinivasan, A., Dellit, T. H., Falck-Ytter, Y. T., & Fishman, N. O. (2016). Implementing an antibiotic stewardship program: guidelines by the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America. Clinical infectious diseases, 62(10), e51–e77.
Basir, S., Khan, M. S., Sohail, S., Irshad, S. U., Saifan, A. M., & Ullah, I. (2025). Drivers of antibiotic misuse and resistance in Pakistan: a public health challenge. Annals of Medicine and Surgery, 87(12).
Boreland, S. (2013). Audit of the Trust’s quality account antibiotic indicators for correct use in paediatrics. Archives of Disease in Childhood, 98(6), e1–e1. https://doi.org/10.1136/archdischild-2013-303935a.24
Charani, E., Edwards, R., Sevdalis, N., Alexandrou, B., Sibley, E., Mullett, D., Franklin, B. D., & Holmes, A. (2011). Behavior change strategies to influence antimicrobial prescribing in acute care: a systematic review. Clinical infectious diseases, 53(7), 651–662.
Committee, J. F. (2012). British national formulary (Vol. 64). Pharmaceutical Press.
Curran, J., Lo, J., Leung, V., Brown, K., Schwartz, K. L., Daneman, N., Garber, G., Wu, J. H., & Langford, B. J. (2022). Estimating daily antibiotic harms: an umbrella review with individual study meta-analysis. Clinical Microbiology and Infection, 28(4), 479–490.
Damessa, M., Assefa, D., Hasen, G., Umeta, B., Melaku, T., Kinati, G., Abdulsemed, K. A., Kebede, D., Waktola, H. D., Gudina, E. K., & Suleman, S. (2026). A multicenter point-prevalence survey of antibiotic utilization patterns in Ethiopia: implications for strengthening stewardship programs. BMC Infectious Diseases, 26(1), 483. https://doi.org/10.1186/s12879-026-12775-z
Garlasco, J., D’Ambrosio, A., Vicentini, C., Quattrocolo, F., & Zotti, C. M. (2024). Impact of hospital-related indicators on healthcare-associated infections and appropriateness of antimicrobial use according to a national dataset. Scientific Reports, 14(1), 31259. https://doi.org/10.1038/s41598-024-82663-6
Gobezie, M. Y., Tesfaye, N. A., Faris, A. G., & Hassen, M. (2024). Surveillance of antimicrobial utilization in Africa: a systematic review and meta-analysis of prescription rates, indications, and quality of use from point prevalence surveys. Antimicrob Resist Infect Control, 13(1), 101. https://doi.org/10.1186/s13756-024-01462-w
Gulliford, M. C., Moore, M. V., Little, P., Hay, A. D., Fox, R., Prevost, A. T., Juszczyk, D., Charlton, J., & Ashworth, M. (2016). Safety of reduced antibiotic prescribing for self limiting respiratory tract infections in primary care: cohort study using electronic health records. bmj, 354.
Hirosawa, T., Sakamoto, T., Hanai, S., Harada, Y., & Shimizu, T. (2023). Effect of Prior Antibiotic Treatment on Blood Culture in an Outpatient Department of General Internal Medicine: A Retrospective Case-Control Analysis. Int J Gen Med, 16, 2709–2717. https://doi.org/10.2147/ijgm.S416235
Itaeli, A. M., Joseph, P. E., Sunguya, B. F., & Bwire, G. M. (2025). Rate of bacterial positivity following antibiotic initiation: a systematic review and meta-analysis. Syst Rev, 15(1), 25. https://doi.org/10.1186/s13643-025-03032-6
Jawhar, D. S., Khan, A. H., & Alam, K. (2025). Systematic review and meta-analysis protocol of impact of pharmacist-led antibiotic stewardship audit-feedback intervention. MethodsX, 14, 103399. https://doi.org/10.1016/j.mex.2025.103399
Jawhar, D. S., Khan, A. H., Alam, K., & Ahmad, R. (2026). Impact of pharmacist-led antibiotic stewardship audit-feedback intervention; systematic review and meta-analysis. Research in Social and Administrative Pharmacy, 22(3), 415–424. https://doi.org/https://doi.org/10.1016/j.sapharm.2025.11.002
Kasse, G. E., Cosh, S. M., Humphries, J., & Islam, M. S. (2024). Antimicrobial prescription pattern and appropriateness for respiratory tract infection in outpatients: a systematic review and meta-analysis. Syst Rev, 13(1), 229. https://doi.org/10.1186/s13643-024-02649-3
Kingdom, G. o. U. (2019). Contained and controlled: The UK’s 20-year vision for antimicrobial resistance https://assets.publishing.service.gov.uk/media/5c48896a40f0b616fe901e91/uk-20-year-vision-for-antimicrobial-resistance.pdf
Naghavi, M., Vollset, S. E., Ikuta, K. S., Swetschinski, L. R., Gray, A. P., Wool, E. E., Robles Aguilar, G., Mestrovic, T., Smith, G., Han, C., Hsu, R. L., Chalek, J., Araki, D. T., Chung, E., Raggi, C., Gershberg Hayoon, A., Davis Weaver, N., Lindstedt, P. A., Smith, A. E.,…Murray, C. J. L. (2024). Global burden of bacterial antimicrobial resistance 1990–2021: a systematic analysis with forecasts to 2050. The Lancet, 404(10459), 1199–1226. https://doi.org/10.1016/S0140-6736(24)01867-1
Ndaki, P. M., Mwanga, J. R., Mushi, M. F., Konje, E. T., Mwita, S. M., & Mshana, S. E. (2025). Drivers of inappropriate use of antibiotics among community members in low- and middle-income countries: a systematic review of qualitative studies. BMC Public Health, 25(1), 705. https://doi.org/10.1186/s12889-025-21553-6
NICE. (2015). Antimicrobial stewardship: systems and processes for effective antimicrobial medicine use, in NICE guideline [NG15]. In.
Noone, M. (2025). Pre-analytical delay of blood cultures which hinders the management of sepsis and fosters the emergence of antimicrobial resistance is an adverse effect of laboratory centralisation. medRxiv, 2025.2006. 2009.25329298.
Núñez-Núñez, M., Perez-Galera, S., Girón-Ortega, J. A., Sandoval Fernández-Del-Castillo, S., Beltrán-García, M., De Cueto, M., Suárez-Barrenechea, A. I., Palacios-Baena, Z. R., Terol-Barrero, P., Oltra-Hostalet, F., Arenzana-Seisdedos, Á., Rodriguez-Baño, J., & Retamar-Gentil, P. (2022). Predictors of inappropriate antimicrobial prescription: Eight-year point prevalence surveys experience in a third level hospital in Spain. Front Pharmacol, 13, 1018158. https://doi.org/10.3389/fphar.2022.1018158
Organization, W. H. (2019). The 2019 WHO AWaRe classification of antibiotics for evaluation and monitoring of use.
Owens, R., Bamford, K., Pinion, S., Garry, E., Cranmer, E., Pearce, C., Wint, H. h., Gill, S., Philips, R., Khan, A., Roy Bentley, S., Roberts, N., Keating, B., Askaroff, N., Morphew, M., Orr, C., Mouket, T., Pope, K., & Powell, N. (2024). Assessment of the appropriateness of antibiotic prescribing in an acute UK hospital using a national audit tool: a single centre retrospective survey. European Journal of Hospital Pharmacy, 31(6), 505–510. https://doi.org/10.1136/ejhpharm-2022-003569
Palos, C., Ierano, C., James, R., Paiva, J. A., Thursky, K., & Sousa, P. (2025). Cultivating global antimicrobial stewardship: prescribing quality and implementability insights from Portugal’s First Hospital National Antimicrobial Prescribing Survey. Antimicrob Resist Infect Control, 15(1), 11. https://doi.org/10.1186/s13756-025-01681-9
Rajendran, R., Chitrapady, S., Tejashree, M. U., Haritha, K., Balakrishnan, J. M., Nair, S., Karattuthodi, M. S., Khan, S., Shalini, S., Uday Kumar, R., Vajid, N. V., & Thunga, G. (2025). Antimicrobial stewardship programs in primary and secondary care settings in India: current challenges, facilitators, perceptions, and impact - a scoping review. BMC Infect Dis, 25(1), 1539. https://doi.org/10.1186/s12879-025-11851-0
Rand, K. H., Beal, S. G., Rivera, K., Allen, B., Payton, T., & Lipori, G. P. (2019). Hourly Effect of Pretreatment With IV Antibiotics on Blood Culture Positivity Rate in Emergency Department Patients. Open Forum Infect Dis, 6(5), ofz179. https://doi.org/10.1093/ofid/ofz179
Razaq, S., Raza, W., & Jenkins, A. (2024). P25 Nowhere to hide: broad-spectrum antimicrobial guideline adherence in outpatients. JAC-Antimicrobial Resistance, 6(Supplement_1), dlad143. 029.
Roy-Bentley, S., Bethune, R., & Powell, N. (2022). Implementation of the Antimicrobial Review Kit (ARK) to optimise antimicrobial prescribing at the Royal Cornwall Hospital: a behavioural change odyssey. Clin Med (Lond), 22(5), 455–460. https://doi.org/10.7861/clinmed.2021-0757
Tafish, R. T., Al-Zayer, R., Al-Anazi, F., & Al-Mulki, J. (2025). Maximizing cost savings and clinical outcomes: A retrospective analysis of antimicrobial stewardship for meropenem utilization in Saudi Arabia. PLoS One, 20(7), e0328673. https://doi.org/10.1371/journal.pone.0328673
Willemsen, I., Van Der Kooij, T., Van Benthem, B., Wille, J., & Kluytmans, J. (2010). Appropriateness of antimicrobial therapy: a multicentre prevalence survey in the Netherlands, 2008–2009. Euro Surveill, 15(46), 19715.
Woh, P. Y., & Zhang, X. (2025). The burden of ESKAPE pathogen-related hospital-acquired infections: clinical and financial perspective from a systematic review. Journal of Hospital Infection, 162, 377–385. https://doi.org/https://doi.org/10.1016/j.jhin.2025.06.006
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Rand Izzet Abdulhadi Nakash
This work is licensed under a Creative Commons Attribution 4.0 International License.
